First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients
April 21, 2015 at 08:03 AM EDT
Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) today announced updated clinical data from a multi-arm Phase 1 study of MM-141, a ...